Remepy
Merav Catalogna, PhD is currently serving as the Director of Neuroscience at Remepy. Prior to this role, Merav held the title of Research Scientist at The Sagol Center for Hyperbaric Medicine and Research, Assaf Harofeh Medical Center. Merav also co-founded TeslaCare and acted as the Chief Scientific Officer. Merav holds a PhD in Bio-Medical Engineering, an MSc in Bio-Medical Engineering, and a BSc in Physics from Tel Aviv University.
This person is not in any offices
Remepy
Remepy is Pioneering Hybrid Drugs™. We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.